Mark L Wolraich

Summary

Affiliation: University of Oklahoma Health Sciences Center
Country: USA

Publications

  1. ncbi The psychometric properties of the vanderbilt attention-deficit hyperactivity disorder diagnostic teacher rating scale in a community population
    Mark L Wolraich
    Section of Developmental and Behavioral Pediatrics, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA
    J Dev Behav Pediatr 34:83-93. 2013
  2. ncbi Pediatricians' attitudes and practices on ADHD before and after the development of ADHD pediatric practice guidelines
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, OK, USA
    J Atten Disord 13:563-72. 2010
  3. ncbi Attention-deficit hyperactivity disorder
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
    Semin Pediatr Neurol 13:279-85. 2006
  4. ncbi Stimulant medications and their adverse events and the food and drug administration: what can we conclude?
    Mark L Wolraich
    J Dev Behav Pediatr 27:177-8. 2006
  5. ncbi Intervening to improve communication between parents, teachers, and primary care providers of children with ADHD or at high risk for ADHD
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, OK, USA
    J Atten Disord 9:354-68. 2005
  6. ncbi Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
    Pediatrics 115:1734-46. 2005
  7. ncbi Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, Child Study Center, Oklahoma City, Oklahoma 73117, USA
    CNS Drugs 18:243-50. 2004
  8. ncbi Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder
    Mark L Wolraich
    Department of Pediatrics, Child Study Center, University of Oklahoma Health Sciences Center, Oklahoma City 73117, USA
    J Dev Behav Pediatr 25:41-7. 2004
  9. ncbi Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population
    Mark L Wolraich
    Child Study Center, University of Oklahoma Health Sciences Center, Oklahoma City Oklahoma 73117, USA
    J Pediatr Psychol 28:559-67. 2003
  10. ncbi Teachers' screening for attention deficit/hyperactivity disorder: comparing multinational samples on teacher ratings of ADHD
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, USA
    J Abnorm Child Psychol 31:445-55. 2003

Detail Information

Publications19

  1. ncbi The psychometric properties of the vanderbilt attention-deficit hyperactivity disorder diagnostic teacher rating scale in a community population
    Mark L Wolraich
    Section of Developmental and Behavioral Pediatrics, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA
    J Dev Behav Pediatr 34:83-93. 2013
    ..This study examined the psychometric properties of the Vanderbilt AD/HD Diagnostic Teacher Rating Scale (VADTRS)...
  2. ncbi Pediatricians' attitudes and practices on ADHD before and after the development of ADHD pediatric practice guidelines
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, OK, USA
    J Atten Disord 13:563-72. 2010
    ..Method: The study assesses AAP-initiated surveys that were conducted between 1999 and 2005 and involving a random sample of 1,000 and 1,603 pediatricians, respectively...
  3. ncbi Attention-deficit hyperactivity disorder
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
    Semin Pediatr Neurol 13:279-85. 2006
    ..The 2 treatments with demonstrated efficacy for ADHD are medications (stimulant medications and a selective norepinephrine reuptake inhibiter) and behavior-modification programs...
  4. ncbi Stimulant medications and their adverse events and the food and drug administration: what can we conclude?
    Mark L Wolraich
    J Dev Behav Pediatr 27:177-8. 2006
  5. ncbi Intervening to improve communication between parents, teachers, and primary care providers of children with ADHD or at high risk for ADHD
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, OK, USA
    J Atten Disord 9:354-68. 2005
    ..Results suggest that the interventions are insufficient to cause significant increase in communication. Future attempts to improve parent-teacher-provider coordination should be continuing rather than single-session interventions...
  6. ncbi Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
    Pediatrics 115:1734-46. 2005
    ..The article also indicates that research is needed to identify the unique adolescent characteristics of ADHD and effective psychosocial and pharmacologic treatments...
  7. ncbi Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, Child Study Center, Oklahoma City, Oklahoma 73117, USA
    CNS Drugs 18:243-50. 2004
    ..While pharmacokinetic differences appear to exist between some of these new formulations, there are currently no clinical data available to demonstrate clinical efficacy differences between them...
  8. ncbi Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder
    Mark L Wolraich
    Department of Pediatrics, Child Study Center, University of Oklahoma Health Sciences Center, Oklahoma City 73117, USA
    J Dev Behav Pediatr 25:41-7. 2004
    ..The recommendation of multiple informants significantly decreased the prevalence. Allowing for observer disagreement by using more lenient core symptom scores could reduce the effect...
  9. ncbi Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population
    Mark L Wolraich
    Child Study Center, University of Oklahoma Health Sciences Center, Oklahoma City Oklahoma 73117, USA
    J Pediatr Psychol 28:559-67. 2003
    ..DSM-IV). The VADPRS was created to collect uniform patient data and minimize the time burden of lengthy interviews...
  10. ncbi Teachers' screening for attention deficit/hyperactivity disorder: comparing multinational samples on teacher ratings of ADHD
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, USA
    J Abnorm Child Psychol 31:445-55. 2003
    ..Between-site differences were statistically significant, but so small that we conclude that same measurement model fits all 4 samples in 2 continents...
  11. ncbi Annotation: The use of psychotropic medications in children: an American view
    Mark L Wolraich
    Oklahoma University Health Sciences Center, USA
    J Child Psychol Psychiatry 44:159-68. 2003
    ..Psychotropic medications have become an integral component in the treatment of children with mental illnesses...
  12. ncbi The psychometric properties of the vanderbilt attention-deficit hyperactivity disorder diagnostic parent rating scale in a community population
    David E Bard
    Section of Developmental and Behavioral Pediatrics, Department of Pediatrics, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA
    J Dev Behav Pediatr 34:72-82. 2013
    ..To examine the psychometric properties of the Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS) using a community-based sample of primarily elementary and middle school-aged children...
  13. ncbi Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations
    Mark L Wolraich
    University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73117, USA
    Drug Saf 30:17-26. 2007
    ..When the risks are juxtaposed to the clear efficacy in significantly reducing dysfunctional symptoms of ADHD, benefit-risk analyses support the continued use of these pharmacological treatments for patients with ADHD...
  14. ncbi Treatment of attention-deficit/hyperactivity disorder: overview of the evidence
    Ronald T Brown
    Pediatrics 115:e749-57. 2005
    ..Comparison among stimulants (mainly methylphenidate and amphetamines) did not indicate that 1 class outperformed the other...
  15. ncbi ADHD service use patterns in youth
    Laurel K Leslie
    Child and Adolescent Services Research Center, Pediatrics Department at the University of California, San Diego, CA, USA
    J Pediatr Psychol 32:695-710. 2007
    ..To review what is currently known about service use by youth with attention-deficit/hyperactivity disorder (ADHD) and discuss research and policy implications...
  16. ncbi ADHD service use patterns in youth
    Laurel K Leslie
    Child and Adolescent Services Research Center CASRC, Pediatrics Department at the University of California San Diego, San Diego, CA 92123, USA
    Ambul Pediatr 7:107-20. 2007
    ..To review what is currently known about service use by youth with attention-deficit/hyperactivity disorder (ADHD) and discuss research and policy implications...
  17. ncbi Attention-deficit/hyperactivity disorder
    Mark L Wolraich
    Pediatr Ann 37:7-8. 2008
  18. ncbi History of developmental-behavioral pediatrics
    Mark L Wolraich
    J Dev Behav Pediatr 24:215-6; author reply 216. 2003
  19. ncbi Attention-deficit/hyperactivity disorder: issues for the pediatric office
    Mark L Wolraich
    Pediatr Ann 31:469-70. 2002